Abstract 107: Galectin-1 plays a critical role in normal and neoplastic mammary gland morphogenesis and metastatic spreading in breast cancer
Rattachement africain : ar. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Galectins are a family of glycan-binding proteins that regulate neoplastic transformation, angiogenesis, cell adhesion and tumor-immune escape. Galectin-1 (Gal-1), a prototype member of this family, binds to multiple N-acetyllactosamine units in N- and O-glycans on cell surface glycoproteins. Biologically, Gal-1 plays a key role in the creation of an immunosuppressed tumor microenvironment (TME) by acting as a negative regulator of the immune response, fostering tumor immune-escape, stimulating an invasive, stem-like phenotype and enhancing metastasis in several tumors. In this work we focus on the relevance of the Gal-1-glycan axis in the TME, metastatic progression and antitumor immune response, and we aim to address the role that Gal-1 plays in normal and transformed mammary gland development. First, we observed that C57BL/6 female mice deficient for Gal-1 (Lgals1-/- KO) have an impaired mammary branch morphogenesis in response to progesterone stimulus as compared to their C57BL/6 WT counterparts. To tackle the mechanism underlying this deficiency in mammary branching, we performed cell sorting based on surface markers (EpCAM and CD49f)to categorize the isolated mammary cells from C57BL/6 WT and C57BL/6 Lgals1-/- KO mice into four main populations: luminal (EpCAMhigh-CD49flow), basal (EpCAMlow-CD49fmed), stromal (EpCAMneg-CD49fneg), and mammary stem cells (MaSC) (EpCAMlow-CD49fhigh). Each population’s purity was evaluated by Real Time PCR (qPCR) using specific markers (PR, ER, Vim, a-SMA, Nanog) and we observed that Lgals1-/- KO mice present a decreased percentage of luminal and MaSC cells (Spectral CyTEK) in comparison to the Gal-1 sufficient strain, which may contribute to the reduced branching. To then analyze the role of Gal-1 in mammary tumorigenesis and metastasis, we developed a MMTV-PyMT transgenic mouse model WT or KO for Gal-1 (lgals1-/-).Using this novel experimental model, we observed that that PyMT-Gal1-KO mice present a delay in tumor burden and a longer tumor-free survival time, with an overall lower number of transformed ducts in the mammary gland and reduced lung metastasis, alongside a reduced mammary gland branching morphogenesis. Our findings highlight the relevance of Gal-1 in regulating normal mammary gland morphogenesis and assert its critical role in metastatic spreading in breast cancer. From a therapeutical point of view, Gal-1 can be considered as a promising target in metastatic breast cancer. Citation Format: Magali Berton, Ramiro Perrotta, Tomás Dalotto-Moreno, Mahmoud D. Yamil, Sabrina Gatto, Rosa Morales, Gabriel A. Rabinovich, Mariana Salatino. Galectin-1 plays a critical role in normal and neoplastic mammary gland morphogenesis and metastatic spreading in breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 107.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Abstract 107: Galectin-1 plays a critical role in normal and neoplastic mammary gland morphogenesis and metastatic spreading in breast cancer
- Date Crossref
- 21/04/2025
- Éditeur
- American Association for Cancer Research (AACR)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.